20/20 GeneSystems Wins $3M in SBIR Grants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – 20/20 GeneSystems, a Rockville, Md.-based firm developing companion diagnostics, today said that it has received $3 million in Small Business Innovative Research grants to develop tests to help oncologists predict the effectiveness of targeted cancer therapies.

The grants came from the National Cancer Institute's SBIR program and included a $2.75 million Phase IIB "Bridge Award," and a $200,000 Phase I SBIR contract.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.